These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 23715160)
1. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160 [TBL] [Abstract][Full Text] [Related]
2. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451 [TBL] [Abstract][Full Text] [Related]
3. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer. Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120 [TBL] [Abstract][Full Text] [Related]
4. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery]. Yang ZJ; Wei RJ; Li L Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188 [TBL] [Abstract][Full Text] [Related]
6. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917 [TBL] [Abstract][Full Text] [Related]
7. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980 [TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes. Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Wang LB; Teng RY; Jiang ZN; Hu WX; Dong MJ; Yuan XM; Chen WJ; Jin M; Shen JG J Surg Oncol; 2012 Mar; 105(3):293-6. PubMed ID: 21882201 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer. Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597 [TBL] [Abstract][Full Text] [Related]
14. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China. Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272 [TBL] [Abstract][Full Text] [Related]
15. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma. Cabau M; Luc G; Terrebonne E; Belleanne G; Vendrely V; Sa Cunha A; Collet D Am J Surg; 2013 Jun; 205(6):711-7. PubMed ID: 23422318 [TBL] [Abstract][Full Text] [Related]
16. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885 [TBL] [Abstract][Full Text] [Related]
18. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079 [TBL] [Abstract][Full Text] [Related]
19. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer. Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382 [TBL] [Abstract][Full Text] [Related]